Ann: Encouraging Phase II TACTI-002 data reported at SITC 2020, page-12

good steady data in my mind, a real sound basis to expand research, 5 people will think it's absolutely
fabulous data......Mercks enthusiasm in regard to continuing the collaboration will be interesting
and strategic to immuteps future in this regard...We will have to wait and see on that...
@hodgie, going from memory here mate but I think the head and neck cancer trial was a
a couple of months behind the lung cancer combo.....
Those spider plots seem to be showing the longer trials go the better they are getting.....
@tuts, thanks for the summary....
Too many traders involved today to get a true indication of market reaction, that will settle down
but geez it's a pain in the arse...